2006 Patients Sleep Topical 
The Cannigma
APRIL 14, 2021
Ross did become a doctor in the end, but a major part of her work as a neuroscientist involves helping patients find relief through the use of medicinal cannabis. While studying for her PhD at the University of Texas Southwestern in 2006, she was assigned a paper about how cannabinoids affect the brain.
Kind Meds (Cannabis Education Blog)
SEPTEMBER 13, 2022
CBD and THC are the two foremost cannabinoid compounds available in products from smokeable flower to edibles, topicals, and more. THC may relieve muscle-related ailments such as cramps, sleep discomfort or nightmares, and stiff muscle tissues. Patients may experience relief from pain, anxiety, insomnia, and more. 1] Pacher, P.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Greencamp
JANUARY 22, 2019
Grasping the complex interaction between the immune system and cannabis might be complicated at first, but the whole topic becomes much clearer once you become familiar with several important facts. Insomnia and other sleep disorders. This function is best visible in the case of cancer and HIV/AIDS patients.
Greencamp
AUGUST 16, 2018
Because of the very rapid progression of ALS in the majority of patients, understanding how cannabis could help in the alleviation of symptoms is incredibly important for ALS sufferers. Both upper and lower motor neurons suffer severe damage in ALS patients. As few as 10% of ALS patients live longer than 10 years after being diagnosed.
MMJ Recs
APRIL 19, 2018
Between 2006 and 2013, the use of cannabis by senior citizens (over the age of 65) increased by an astounding 250 percent. Additionally, medical cannabis can be useful in treating pain – without the patient having to rely on harmful prescription painkillers. Around 80 percent of deaths related to anorexia are among elderly patients.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and related substance misuse are complex issues impacting family medicine, patient health, and public health. Barriers to facilitating both clinical and public health research regarding marijuana is detrimental to treating patients and the health of the public. Executive Summary. Relevant AAFP Policy. Call to Action.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).
Expert insights. Personalized for you.
126 
Let's personalize your content